| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/20/2010 | US7700119 85kDa neisserial antigen |
| 04/20/2010 | US7700117 Camp factor of Streptococcus uberis |
| 04/20/2010 | US7700114 original codons are exchanged by codons which lead to an enhanced translation in a mammalian cell, contain a deletion resulting in the production of a truncated non-functional protein; capable of enhancing the immunogenicity |
| 04/20/2010 | US7700106 Therapeutic agent for ulcerative colitis |
| 04/20/2010 | US7700104 Attenuated Salmonella SP12 mutants as antigen carriers |
| 04/20/2010 | US7700092 Pneumovirus NS proteins antagonize the interferon IFN response |
| 04/20/2010 | US7700087 Compounds and methods to inhibit or augment an inflammatory response |
| 04/20/2010 | CA2418744C Novel aminocyclohexane derivatives |
| 04/20/2010 | CA2417475C Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacterien |
| 04/20/2010 | CA2410579C Methods and compositions for treating flaviviruses and pestiviruses |
| 04/20/2010 | CA2388240C Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 04/20/2010 | CA2379727C Use of propionic bacteria for producing propionic acid and/or propionates in the colon |
| 04/20/2010 | CA2359573C Conjugates of colony stimulating factors for targeting and imaging infection and inflammation |
| 04/20/2010 | CA2348741C Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use |
| 04/20/2010 | CA2180872C Composition containing nucleic acids, preparation and uses |
| 04/15/2010 | WO2010042919A2 Method of making a vaccine |
| 04/15/2010 | WO2010042851A1 Antibacterial aminoglycoside analogs |
| 04/15/2010 | WO2010042850A1 Antibacterial aminoglycoside analogs |
| 04/15/2010 | WO2010042817A1 Use of hiv mosaic envelope proteins to optimize t-cell responses against hiv envelope |
| 04/15/2010 | WO2010042755A2 Chimeric therapeutics, compositions, and methods for using same |
| 04/15/2010 | WO2010042683A1 Treating hepatitis c virus infection with over-expression of microrna-196 |
| 04/15/2010 | WO2010042633A2 Naringenin complexes and methods of use thereof |
| 04/15/2010 | WO2010042549A1 Inhalation of levofloxacin for reducing lung inflammation |
| 04/15/2010 | WO2010042548A2 Methods of treating inflammation |
| 04/15/2010 | WO2010042547A1 Compositions and methods for inhibiting expression of an rna from west nile virus |
| 04/15/2010 | WO2010042481A1 Compositions and methods related to bacterial eap, emp, and/or adsa proteins |
| 04/15/2010 | WO2010042445A1 Carbazole compounds and therapeutic uses of the compounds |
| 04/15/2010 | WO2010042392A2 Hiv integrase inhibitors |
| 04/15/2010 | WO2010042391A2 Hiv integrase inhibitors |
| 04/15/2010 | WO2010041938A2 New virulence factors of streptococcus pneumoniae |
| 04/15/2010 | WO2010041746A1 Helicobacter pylori bacterium proliferation inhibitor |
| 04/15/2010 | WO2010041703A1 Anti-sars coronavirus agent, and product containing anti-sars coronavirus agent |
| 04/15/2010 | WO2010041702A1 Anti-avian influenza virus agent, and product containing anti-avian influenza virus agent |
| 04/15/2010 | WO2010041699A1 Btma2 compound |
| 04/15/2010 | WO2010041400A1 Biofilm formation inhibitor |
| 04/15/2010 | WO2010041219A1 2-benzothiophenyl-and 2-naphthyl-0xaz0lidin0nes and their azaisostere analogues as antibacterial agents |
| 04/15/2010 | WO2010041194A1 Tricyclic oxazolidinone antibiotic compounds |
| 04/15/2010 | WO2010041143A2 Oral vaccines for producing mucosal immunity |
| 04/15/2010 | WO2010041112A1 Novel combinations of antibacterial nitrogenous heterocyclic compounds with other antibacterial compounds, and use thereof as drugs |
| 04/15/2010 | WO2010041108A1 Nitrogenous heterocyclic compounds, preparation thereof, and use thereof as antibacterial agents |
| 04/15/2010 | WO2010040839A1 Antimicrobial compositions and uses |
| 04/15/2010 | WO2010040762A1 New amide compounds as boosters of antivirals |
| 04/15/2010 | WO2010040281A1 Humanized antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof |
| 04/15/2010 | WO2010040275A1 The 2-(4-substituted phenylamino) polysubstituted pyridine compounds as the inhibitors of non-nucleoside hiv reverse transcriptase, praparation methods and uses thereof |
| 04/15/2010 | WO2010040272A1 Amide compounds, their pharmaceutical compositions, their preparation and their use |
| 04/15/2010 | WO2010040254A1 The use of flavones from radix scutellariae in manufacture of medicaments for treating enterovirus infection |
| 04/15/2010 | WO2010021717A3 Hcv protease inhibitors |
| 04/15/2010 | WO2010019611A3 Bridged polycyclic compound based compositions for topical and oral applications |
| 04/15/2010 | WO2010014888A3 Use of a pneumococcal p4 peptide for enhancing opsonophagocytosis in response to a pathogen |
| 04/15/2010 | WO2010011845A3 Preventing or treating viral infection using an inhibitor of the lsd1 protein, a mao inhibitor or an inhibitor of lsdl and a mao inhibitor |
| 04/15/2010 | WO2010011611A3 Antimicrobially-primed medicinal maggot therapy |
| 04/15/2010 | WO2009143018A3 Pyrrolo [2, 3-d] pyrimidines as fm and kit kinase modulators |
| 04/15/2010 | WO2009110940A3 Virus-, bacteria-, and fungi-interacting layered phyllosilicates and methods of use |
| 04/15/2010 | US20100094003 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases |
| 04/15/2010 | US20100093864 Anti-infective thiourea compounds |
| 04/15/2010 | US20100093862 Potentiation of cellular immunity using histone deacetylase (hdac) inhibitors. |
| 04/15/2010 | US20100093860 Hydroxybutyrate and poly-hydroxybutyrate as components of animal feed or feed additives |
| 04/15/2010 | US20100093841 Cell culture system of a hepatitis c genotype 3a and 2a chimera |
| 04/15/2010 | US20100093811 Hiv protease inhibitors |
| 04/15/2010 | US20100093798 Cyclic modulators of chemokine receptor activity |
| 04/15/2010 | US20100093792 Crystalline forms of a potent hcv inhibitor |
| 04/15/2010 | US20100093784 Novel heterocyclic nitrogenous compounds, their preparation and their use as antibacterial medicaments |
| 04/15/2010 | US20100093781 Imidazo [1, 2-a] pyrrolo [3, 2-c] pyridine compounds useful as pestivirus inhibitors |
| 04/15/2010 | US20100093779 Hcv ns3 protease inhibitors |
| 04/15/2010 | US20100093769 Compounds |
| 04/15/2010 | US20100093752 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors |
| 04/15/2010 | US20100093737 Nucleoside and Nucleotide Analogues with Quaternary Carbon Centers and Methods of Use |
| 04/15/2010 | US20100093705 Therapeutic agents, and methods of making and using the same |
| 04/15/2010 | US20100093690 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 04/15/2010 | US20100093667 Salts of hiv inhibitor compounds |
| 04/15/2010 | US20100093659 Polyvalent bioconjugates |
| 04/15/2010 | US20100093656 Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents |
| 04/15/2010 | US20100093651 Artemisinin Derivatives |
| 04/15/2010 | US20100093632 Enamel matrix protein composition for treatment of systemic inflammatory response |
| 04/15/2010 | US20100093623 Compositions and methods for modulating nod-like receptor activity and uses thereof |
| 04/15/2010 | US20100093618 Polypeptide capable of inhibiting hiv-1 transcription and replication and uses thereof |
| 04/15/2010 | US20100093617 Use |
| 04/15/2010 | US20100092997 Method of Enhancing of Binding Activity of Antibody Composition to FcGamma Receptor IIIa |
| 04/15/2010 | US20100092581 Antibacterial compositions comprising an extract from arceuthobium |
| 04/15/2010 | US20100092526 Nanoemulsion therapeutic compositions and methods of using the same |
| 04/15/2010 | US20100092521 Antigenicity of infectious pancreatic necrosis virus vp2 sub-viral particles expressed in yeast |
| 04/15/2010 | US20100092518 Recombinant Intracellular Pathogen Immunogenic Compositions and Methods of Use |
| 04/15/2010 | US20100092516 Bacterial ghost (bg) production process using betapropiolactone (bpl) for final inactivation |
| 04/15/2010 | US20100092513 Methods and compositions for inducing an immune response to HIV and models for testing |
| 04/15/2010 | US20100092512 Methods for preventing and ameiliorating porcine respiratory and reproductive syndrome virus-associated disease by immunizing against porcine ttv infection |
| 04/15/2010 | US20100092509 Hypo- and Hyper- Acetylated Meningococcal Capsular Saccharides |
| 04/15/2010 | US20100092508 Molecular Antigen Arrays |
| 04/15/2010 | US20100092502 Modified hiv env polypeptides |
| 04/15/2010 | US20100092487 Toxic detection method |
| 04/15/2010 | US20100092479 Compositions and methods for treatment of viral diseases |
| 04/15/2010 | US20100092462 Methods for Suppressing Toll-Like Receptor Activity |
| 04/15/2010 | US20100092443 Novel combinations of nitrogenated heterocyclic antibacterial compounds with other antibacterial compounds and the use of same as drugs |
| 04/15/2010 | US20100092440 composition for the administration of biologically active principles in gynaecologic and rectal field and uses thereof |
| 04/15/2010 | US20100092436 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 04/15/2010 | US20100092427 Pyridinone Diketo Acids: Inhibitors of HIV Replication in Combination Therapy |
| 04/15/2010 | US20100092426 2-substituted benzimidazoles |
| 04/15/2010 | US20100092398 Antimicrobial compositions and applications therefore |
| 04/15/2010 | US20100092388 Anthracycline Derivatives |
| 04/15/2010 | CA2740035A1 Novel combinations of antibacterial nitrogenous heterocyclic compounds with other antibacterial compounds, and use thereof as drugs |
| 04/15/2010 | CA2739948A1 Treating hepatitis c virus infection with over-expression of microrna-196 |